Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01703325Phase 4Completed
Phase 4, randomised, single-blind trial of triamcinolone acetonide in nail psoriasis (3 arms), sponsored by Mahidol University. Primary endpoint: Nail Psoriasis Severity Index at 6 months. Started Nov 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01703325.